(Q73923789)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389914%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Ifosfamide and continuous infusion etoposide in advanced adult soft tissue sarcoma. A Scandinavian Sarcoma Group Phase II Study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389914%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

1 reference

G Saeter

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389914%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

T A Alvegård

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389914%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

O R Monge

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389914%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

H Strander

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389914%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

I Turesson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389914%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

R Klepp

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389914%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Söderberg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389914%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

E Wist

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389914%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

N Raabe

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389914%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Erlanson

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389914%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

O P Solheim

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389914%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

E Hannisdal

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389914%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 September 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389914%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389914%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389914%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389914%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

1551-1558

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389914%20AND%20SRC:MED&resulttype=core&format=json

Does histologic grade in soft tissue sarcoma influence response rate to systemic chemotherapy?

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

Chemotherapy for metastatic soft tissue sarcomas – another full circle?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcom

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

Phase II study of ifosfamide-etoposide-mesna in adults with advanced nonosseous sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

The pharmacology of intravenous and oral etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

VP-16 in advanced soft tissue sarcoma: a phase II study of the EORTC soft tissue and bone sarcoma group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

Chronic oral etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

Prolonged administration of low dose infusional etoposide in patients with advanced malignancies. A phase I/II study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

The clinical pharmacology of etoposide and teniposide

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

Measurement and prediction of the short-term response of soft tissue sarcomas to chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

Tumour suppressor gene products, proliferation, and differentiation markers in lung neuroendocrine neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

Phase II study of VP16-213 (etoposide) in refractory metastatic breast carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

Lung resection for metastatic sarcomas: total survival from primary treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

Resection of lung metastases from soft-tissue sarcomas. A multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

Selected benefits of thoracotomy and chemotherapy for sarcoma metastatic to the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

Response to chemotherapy does not predict survival after resection of sarcomatous pulmonary metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

Randomized study of systemic chemotherapy following complete excision of nonosseous sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

The outcome of advanced soft tissue sarcoma patients with complete tumour regression after either chemotherapy alone or chemotherapy plus surgery. The Scandinavian Sarcoma Group experience

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900102-0

7 January 2021

10.1016/S0959-8049(97)00102-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9389914%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference